Geneos Wealth Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $377K | Sell |
|
|||||
|
2025
Q2 | $415K | Sell |
|
|||||
|
2025
Q1 | $775K | Buy |
|
|||||
|
2024
Q4 | $578K | Sell |
|
|||||
|
2024
Q3 | $388K | Sell |
|
|||||
|
2024
Q2 | $379K | Buy |
|
|||||
|
2024
Q1 | $379K | Buy |
|
|||||
|
2023
Q4 | $629K | Buy |
|
|||||
|
2023
Q3 | $276K | Hold |
|
|||||
|
2023
Q2 | $342K | Hold |
|
|||||
|
2023
Q1 | $361K | Buy |
|
|||||
|
2022
Q4 | $371K | Buy |
|
|||||
|
2022
Q3 | $345K | Sell |
|
|||||
|
2022
Q2 | $399K | Buy |
|
|||||
|
2022
Q1 | $389K | Buy |
|
|||||
|
2021
Q4 | $389K | Hold |
|
|||||
|
2021
Q3 | $402K | Buy |
|
|||||
|
2021
Q2 | $528K | Sell |
|
|||||
|
2021
Q1 | $308K | Buy |
|
|||||
|
2020
Q4 | $366K | Buy |
|
|||||
|
2020
Q3 | $92K | Buy |
|
|||||
|
2020
Q2 | $71K | Hold |
|
|||||
|
2020
Q1 | $40K | Hold |
|
|||||
|
2019
Q4 | $35K | Hold |
|
|||||
|
2019
Q3 | $46K | Hold |
|
|||||
|
2019
Q2 | $47K | Hold |
|
|||||
|
2019
Q1 | $42K | Hold |
|
|||||
|
2018
Q4 | $21K | Hold |
|
|||||
|
2018
Q3 | $38K | Buy |
|